| Akcje zaległe | 4,271,759 shares |
| Akcje insidera | 12 138 101 shares |
Wynik sentymentu insiderów
Ocena sentymentu insiderów pokazuje firmy, które są kupowane przez insiderów korporacyjnych.
Jest to wynik zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje spółki o najwyższym poziomie akumulacji informacji poufnych. Model rankingowy wykorzystuje kombinację liczby netto insiderów kupujących w ciągu ostatnich 90 dni, całkowitej liczby akcji kupionych jako procent akcji w obrocie oraz całkowitej liczby akcji posiadanych przez insiderów. Liczba ta waha się od 0 do 100, przy czym wyższe liczby wskazują na wyższy poziom akumulacji w porównaniu z innymi spółkami, a 50 to średnia.
Częstotliwość aktualizacji: codziennie
Ocena sentymentu kadry kierowniczej
Ocena sentymentu kadry kierowniczej pokazuje, że firmy są kupowane przez urzędników korporacyjnych.
Z definicji dyrektorzy korporacyjni to insiderzy korporacyjni, ale w przeciwieństwie do niektórych innych insiderów (10% akcjonariuszy i członków zarządu), dyrektorzy pracują dla firmy na co dzień i podczas handlu korzystają z własnych pieniędzy. (10% Akcjonariusze i członkowie zarządu często zarządzają funduszami zarządzających pieniędzmi innych osób). W związku z tym transakcje wykorzystujące informacje poufne dokonywane przez osoby z kadry kierowniczej mają znacznie większe znaczenie i powinny być odpowiednio traktowane.
Podobnie jak ocena sentymentu insiderów, ocena sentymentu kadry kierowniczej jest wynikiem zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje firmy o najwyższym poziomie akumulacji urzędników.
Częstotliwość aktualizacji: codziennie
Kluczowe wskaźniki insider
Ta karta pokazuje pozycję firmy według różnych wskaźników insider. Ranking według miary percentyla pokazuje, jak ta firma wypada na tle innych firm na rynkach amerykańskich. Wyższe rankingi wskazują na lepszą sytuację.
Na przykład ogólnie przyjmuje się, że kupowanie przez insiderów jest pozytywnym wskaźnikiem, zatem spółki z większą liczbą takich transakcji plasowałyby się wyżej niż spółki z mniejszą liczbą takich transakcji (lub nawet sprzedaży przez insiderów.
Liczba netto zakupów dokonanych przez insiderów (ranking)
N/A
Liczba netto zakupów dokonanych przez insiderów to łączna liczba insiderów kupujących pomniejszona o całkowitą liczbę insiderów sprzedających w ciągu ostatnich 90 dni. Tutaj pokazana jest miara percentyla (zakres od 0 do 100%).
Procent akcji kupowanych przez insiderów (ranking)
N/A
Procent akcji zakupionych przez insiderów to całkowita liczba akcji zakupionych przez insiderów pomniejszona o całkowitą liczbę akcji sprzedanych przez insiderów w ciągu ostatnich 90 dni, podzielona przez całkowitą liczbę akcji zakupionych przez insiderów i pomnożona przez 100.
Wykres handlu insider
Poniższy wykres przedstawia Histogen Inc. transakcji zrealizowanych przez insiderów. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Ogólnie rzecz biorąc, dokonywanie transakcji w ich firmach przez osoby posiadające dostęp do informacji poufnych w oparciu o istotne, niepubliczne informacje jest generalnie nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4.
Lista insiderów i wskaźniki rentowności
Ta tabela przedstawia listę znanych insiderów i jest generowana automatycznie na podstawie zgłoszeń ujawnianych SEC. Oprócz nazwisk, najnowszego tytułu oraz oznaczenia dyrektora, członka kierownictwa lub 10% właściciela, podajemy najnowsze ujawnione pakiety akcji. Dodatkowo, jeśli to możliwe, udostępniamy historyczne wyniki handlowe danego insidera. Historyczne wyniki handlowe to średnia ważona wyników rzeczywistych transakcji zakupu na otwartym rynku dokonanych przez insiderów. Więcej informacji na temat sposobu obliczania tej wartości obejrzyj webinar na YouTube.
See our leaderboard of most profitable insider traders.
| Insider | Średni zysk (%) | Posiadane Akcje |
Podział korygujący |
|---|
Report errors via our new Insider Auditing Tool
Śledź historię zakupów insiderów — analiza zysków krótkoterminowych
W tej sekcji analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w HSTO / Histogen Inc.. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .
Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Śledź historię sprzedaży insider — analiza strat krótkoterminowych
W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży insidera na otwartym rynku dokonanej w HSTO / Histogen Inc.. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .
Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Historia transakcji
Kliknij ikonę linku, aby zobaczyć pełną historię transakcji. Transakcje zgłoszone w ramach automatycznego planu handlowego 10b5-1 będą oznaczone znakiem X w kolumnie oznaczonej 10b-5.
| Plik Data |
Data transakcji |
Formularz | Wtajemniczony | Serce | Nazwa papieru wartościowego | Kod | Bezpośredni | Cena wykonania |
Cena jednostki |
Zmieniono jednostki |
Zmieniona wartość (1 tys.) |
Pozostałe opcje |
Pozostałe akcje |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-03 | 3 | Spada Alfred P. | HSTO | Common Stock | I | 1 235 | ||||||||
| 2023-02-03 | 3 | Spada Alfred P. | HSTO | Common Stock | D | 979 | ||||||||
| 2022-02-25 | 2022-02-24 | 4 | Mento Steven J | HSTO | Stock Option (right to buy) | D | 0,24 | 151 642 | 151 642 | |||||
| 2022-02-22 | 2022-02-17 | 4 | Knudson Susan A. | HSTO | Stock Option (right to buy) | D | 0,24 | 169 800 | 169 800 | |||||
| 2022-02-22 | 2022-02-17 | 4 | Latterich Martin | HSTO | Stock Option (right to buy) | D | 0,24 | 134 900 | 134 900 | |||||
| 2021-11-10 | 2021-11-08 | 4 | Latterich Martin | HSTO | Restricted Stock Unit | D | 102 880 | 102 880 | ||||||
| 2021-11-10 | 2021-11-08 | 4 | Mento Steven J | HSTO | Restricted Stock Unit | D | 228 395 | 228 395 | ||||||
| 2021-11-10 | 2021-11-08 | 4 | Mento Steven J | HSTO | Stock Option (right to buy) | D | 0,73 | 377 830 | 377 830 | |||||
| 2021-11-10 | 2021-11-08 | 4 | Knudson Susan A. | HSTO | Restricted Stock Unit | D | 137 174 | 137 174 | ||||||
| 2021-09-03 | 2021-09-02 | 4 | KISNER DANIEL L | HSTO | Stock Option (right to buy) | D | 0,82 | 20 000 | 20 000 | |||||
| 2021-09-03 | 2021-09-02 | 4 | Jackson Jonathan | HSTO | Stock Option (right to buy) | D | 0,82 | 20 000 | 20 000 | |||||
| 2021-09-03 | 2021-09-02 | 4 | Crean David Hugh | HSTO | Stock Option (right to buy) | D | 0,82 | 25 000 | 25 000 | |||||
| 2021-09-03 | 2021-09-02 | 4 | Mento Steven J | HSTO | Stock Option (right to buy) | D | 0,82 | 20 000 | 20 000 | |||||
| 2021-09-03 | 2021-09-02 | 4 | Satz Brian | HSTO | Stock Option (right to buy) | D | 0,82 | 20 000 | 20 000 | |||||
| 2021-03-30 | 2021-03-30 | 4 | Pascoe Richard W | HSTO | Common Stock | D | 1,1400 | 20 000 | 23 | 30 000 | ||||
| 2021-03-26 | 2021-03-25 | 4 | Fuhrmann Rochelle | HSTO | Stock Option (right to buy) | D | 1,27 | 30 000 | 30 000 | |||||
| 2021-03-12 | 2021-03-10 | 4 | Windham-Bannister Susan Richards | HSTO | Stock Option (right to buy) | D | 1,23 | 30 000 | 30 000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Pascoe Richard W | HSTO | Stock Option (right to buy) | D | 0,97 | 346 000 | 346 000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Naughton Gail K | HSTO | Stock Option (right to buy) | D | 0,97 | 95 000 | 95 000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Latterich Martin | HSTO | Stock Option (right to buy) | D | 0,97 | 90 000 | 90 000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Knudson Susan A. | HSTO | Stock Option (right to buy) | D | 0,97 | 112 000 | 112 000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Daniels Moya | HSTO | Stock Option (right to buy) | D | 0,97 | 100 000 | 100 000 | |||||
| 2020-12-07 | 2020-12-03 | 4 | Pascoe Richard W | HSTO | Common Stock | D | 1,2394 | 10 000 | 12 | 10 000 | ||||
| 2020-10-19 | 2020-10-16 | 4 | Daniels Moya | HSTO | Stock Option (right to buy) | D | 2,27 | 65 000 | 65 000 | |||||
| 2020-10-09 | 2020-10-07 | 4 | Satz Brian | HSTO | Stock Option (right to buy) | D | 1,89 | 20 000 | 20 000 | |||||
| 2020-10-09 | 2020-10-07 | 4 | Mento Steven J | HSTO | Stock Option (right to buy) | D | 1,89 | 20 000 | 20 000 | |||||
| 2020-10-09 | 2020-10-07 | 4 | Zhang Yizhuo | HSTO | Stock Option (right to buy) | D | 1,89 | 20 000 | 20 000 | |||||
| 2020-10-09 | 2020-10-07 | 4 | Crean David Hugh | HSTO | Stock Option (right to buy) | D | 1,89 | 20 000 | 20 000 | |||||
| 2020-10-09 | 2020-10-07 | 4 | KISNER DANIEL L | HSTO | Stock Option (right to buy) | D | 1,89 | 20 000 | 20 000 | |||||
| 2020-10-09 | 2020-10-07 | 4 | Jackson Jonathan | HSTO | Stock Option (right to buy) | D | 1,89 | 20 000 | 20 000 | |||||
| 2020-10-09 | 2020-10-07 | 4 | Chang Stephen | HSTO | Stock Option (right to buy) | D | 1,89 | 20 000 | 20 000 | |||||
| 2020-05-29 | 2020-05-28 | 4 | Knudson Susan A. | HSTO | Stock Option (right to buy) | D | 4,61 | 124 119 | 124 119 | |||||
| 2020-05-28 | 2018-05-02 | 4 | Crean David Hugh | HSTO | Stock Option (right to buy) | D | 3,84 | 35 855 | 35 855 | |||||
| 2020-05-28 | 2017-10-25 | 4 | Crean David Hugh | HSTO | Stock Option (right to buy) | D | 3,84 | 4 302 | 4 302 | |||||
| 2020-05-28 | 2017-05-22 | 4 | Crean David Hugh | HSTO | Stock Option (right to buy) | D | 3,70 | 17 210 | 17 210 | |||||
| 2020-05-28 | 2020-05-26 | 4 | Zhang Yizhuo | HSTO | Common Stock | I | 600 983 | 600 983 | ||||||
| 2020-05-28 | 2020-05-26 | 4 | Chang Stephen | HSTO | Common Stock | D | 14 485 | 14 485 | ||||||
| 2020-05-28 | 2018-05-02 | 4 | Chang Stephen | HSTO | Stock Option (right to buy) | D | 3,84 | 35 855 | 35 855 | |||||
| 2020-05-28 | 2016-01-29 | 4 | Chang Stephen | HSTO | Stock Option (right to buy) | D | 1,47 | 14 342 | 14 342 | |||||
| 2020-05-28 | 2020-05-26 | 4 | Jackson Jonathan | HSTO | Common Stock | I | 2 356 597 | 2 356 597 | ||||||
| 2020-05-28 | 2020-05-26 | 4 | Latterich Martin | HSTO | Common Stock | D | 11 951 | 11 951 | ||||||
| 2020-05-28 | 2018-03-12 | 4 | Latterich Martin | HSTO | Stock Option (right to buy) | D | 3,84 | 14 342 | 14 342 | |||||
| 2020-05-28 | 2016-10-07 | 4 | Latterich Martin | HSTO | Stock Option (right to buy) | D | 3,70 | 28 684 | 28 684 | |||||
| 2020-05-28 | 2020-05-26 | 4 | Satz Brian | HSTO | Common Stock | D | 1 434 | 1 434 | ||||||
| 2020-05-28 | 2018-05-02 | 4 | Satz Brian | HSTO | Stock Option (right to buy) | D | 3,84 | 35 855 | 35 855 | |||||
| 2020-05-28 | 2020-05-26 | 4 | Naughton Gail K | HSTO | Common Stock | I | 426 526 | 426 526 | ||||||
| 2020-05-28 | 2012-05-12 | 4 | Naughton Gail K | HSTO | Stock Option (right to buy) | D | 0,53 | 380 063 | 380 063 | |||||
| 2020-05-28 | 2019-01-24 | 4 | Pascoe Richard W | HSTO | Stock Option (right to buy) | D | 5,30 | 194 071 | 194 071 | |||||
| 2020-05-28 | 2019-01-24 | 4 | Pascoe Richard W | HSTO | Stock Option (right to buy) | D | 5,30 | 291 107 | 291 107 | |||||
| 2020-05-27 | 2020-05-22 | 4 | Mento Steven J | HSTO | Restricted Stock Units | D | -65 000 | 0 | ||||||
| 2020-05-27 | 2020-05-22 | 4 | Mento Steven J | HSTO | Common Stock | D | 0,5600 | -31 428 | -18 | 39 572 | ||||
| 2020-05-27 | 2020-05-22 | 4 | Mento Steven J | HSTO | Common Stock | D | 65 000 | 71 000 | ||||||
| 2020-05-27 | 2020-05-22 | 4 | Spada Alfred P. | HSTO | Restricted Stock Units | D | -31 343 | 0 | ||||||
| 2020-05-27 | 2020-05-22 | 4 | Spada Alfred P. | HSTO | Common Stock | D | 0,5600 | -12 960 | -7 | 19 595 | ||||
| 2020-05-27 | 2020-05-22 | 4 | Spada Alfred P. | HSTO | Common Stock | D | 31 343 | 32 555 | ||||||
| 2020-05-27 | 2020-05-22 | 4 | Marshall Keith W | HSTO | Restricted Stock Units | D | -38 500 | 0 | ||||||
| 2020-05-27 | 2020-05-22 | 4 | Marshall Keith W | HSTO | Common Stock | D | 0,5600 | -18 615 | -10 | 19 885 | ||||
| 2020-05-27 | 2020-05-22 | 4 | Marshall Keith W | HSTO | Common Stock | D | 38 500 | 38 500 | ||||||
| 2019-11-19 | 2019-11-18 | 4 | Scott Kathleen D. | CNAT | Stock Option (Right to Buy) | D | 0,33 | 30 000 | 30 000 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Marshall Keith W | CNAT | Restricted Stock Units | D | 385 000 | 385 000 | ||||||
| 2019-08-01 | 2019-08-01 | 4 | Marshall Keith W | CNAT | Stock Option (Right to Buy) | D | 2,00 | -175 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Marshall Keith W | CNAT | Stock Option (Right to Buy) | D | 5,17 | -70 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Marshall Keith W | CNAT | Stock Option (Right to Buy) | D | 5,74 | -525 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Restricted Stock Units | D | 313 436 | 313 436 | ||||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 2,00 | -175 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 5,17 | -70 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 4,21 | -100 625 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 1,85 | -21 875 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 1,85 | -109 375 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 6,40 | -100 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 9,45 | -50 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Restricted Stock Units | D | 86 375 | 86 375 | ||||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 2,00 | -50 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 5,17 | -16 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 4,21 | -23 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 2,09 | -20 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 1,85 | -3 750 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 1,85 | -15 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 9,61 | -15 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 6,40 | -15 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 9,45 | -15 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Restricted Stock Units | D | 650 000 | 650 000 | ||||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 2,00 | -350 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 5,17 | -120 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 4,21 | -172 500 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 1,85 | -37 500 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 1,85 | -20 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 6,40 | -50 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 6,40 | -150 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 9,45 | -400 000 | 0 | |||||
| 2019-07-01 | 2019-06-27 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 0,29 | 45 000 | 45 000 | |||||
| 2019-07-01 | 2019-06-27 | 4 | KISNER DANIEL L | CNAT | Stock Option (Right to Buy) | D | 0,29 | 20 000 | 20 000 | |||||
| 2019-07-01 | 2019-06-27 | 4 | Klassen Preston | CNAT | Stock Option (Right to Buy) | D | 0,29 | 20 000 | 20 000 | |||||
| 2019-07-01 | 2019-06-27 | 4 | LARUE WILLIAM R | CNAT | Stock Option (Right to Buy) | D | 0,29 | 20 000 | 20 000 | |||||
| 2019-07-01 | 2019-06-27 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 0,29 | 20 000 | 20 000 | |||||
| 2019-02-11 | 2019-02-07 | 4 | RIPLEY DANIEL L. | CNAT | Stock Option (Right to Buy) | D | 2,00 | 100 000 | 100 000 | |||||
| 2019-02-11 | 2018-11-14 | 4 | RIPLEY DANIEL L. See footnote. | CNAT | Common Stock | I | 3,1500 | 1 861 | 6 | 32 431 | ||||
| 2019-02-11 | 2018-05-14 | 4 | RIPLEY DANIEL L. See footnote. | CNAT | Common Stock | I | 3,3100 | 1 290 | 4 | 30 570 | ||||
| 2019-02-11 | 2019-02-07 | 4 | Marshall Keith W | CNAT | Stock Option (Right to Buy) | D | 2,00 | 175 000 | 175 000 | |||||
| 2019-02-11 | 2019-02-07 | 4 | Smith Edward F III | CNAT | Stock Option (Right to Buy) | D | 2,00 | 100 000 | 100 000 | |||||
| 2019-02-11 | 2018-11-14 | 4 | Smith Edward F III | CNAT | Common Stock | D | 3,1500 | 1 724 | 5 | 10 875 | ||||
| 2019-02-11 | 2018-05-14 | 4 | Smith Edward F III | CNAT | Common Stock | D | 3,3100 | 4 690 | 16 | 9 151 | ||||
| 2019-02-11 | 2019-02-07 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 2,00 | 175 000 | 175 000 | |||||
| 2019-02-11 | 2019-02-07 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 2,00 | 50 000 | 50 000 | |||||
| 2019-02-11 | 2019-02-07 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 2,00 | 350 000 | 350 000 | |||||
| 2019-02-11 | 2019-02-07 | 4 | Hagerty David T | CNAT | Stock Option (Right to Buy) | D | 2,00 | 175 000 | 175 000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | KISNER DANIEL L | CNAT | Stock Option (Right to Buy) | D | 4,99 | 20 000 | 20 000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | Klassen Preston | CNAT | Stock Option (Right to Buy) | D | 4,99 | 20 000 | 20 000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | LARUE WILLIAM R | CNAT | Stock Option (Right to Buy) | D | 4,99 | 20 000 | 20 000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | Scopa James Paul | CNAT | Stock Option (Right to Buy) | D | 4,99 | 20 000 | 20 000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 4,99 | 20 000 | 20 000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 4,99 | 45 000 | 45 000 | |||||
| 2018-05-07 | 2018-05-04 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 0,99 | -60 000 | 147 070 | |||||
| 2018-05-07 | 2018-05-04 | 4 | Mento Steven J | CNAT | Common Stock | D | 0,9900 | 60 000 | 59 | 60 000 | ||||
| 2018-03-01 | 2018-02-27 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 1,24 | -12 121 | 0 | |||||
| 2018-03-01 | 2018-02-27 | 4 | Spada Alfred P. | CNAT | Common Stock | D | 1,2400 | 12 121 | 15 | 12 121 | ||||
| 2018-02-05 | 2017-05-30 | 5 | VANDERTIE MICHELLE L See footnote. | CNAT | Common Stock | I | -2 165 | 2 813 | ||||||
| 2018-02-05 | 2018-02-04 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 5,17 | 120 000 | 120 000 | |||||
| 2018-02-05 | 2018-02-04 | 4 | Hagerty David T | CNAT | Stock Option (Right to Buy) | D | 5,17 | 70 000 | 70 000 | |||||
| 2018-02-05 | 2018-02-04 | 4 | Marshall Keith W | CNAT | Stock Option (Right to Buy) | D | 5,17 | 70 000 | 70 000 | |||||
| 2018-02-05 | 2018-02-04 | 4 | RIPLEY DANIEL L. | CNAT | Stock Option (Right to Buy) | D | 5,17 | 40 000 | 40 000 | |||||
| 2018-02-05 | 2017-11-14 | 4 | RIPLEY DANIEL L. See footnote. | CNAT | Common Stock | I | 3,4800 | 818 | 3 | 29 280 | ||||
| 2018-02-05 | 2017-05-12 | 4 | RIPLEY DANIEL L. See footnote. | CNAT | Common Stock | I | 1,7000 | 761 | 1 | 28 462 | ||||
| 2018-02-05 | 2018-02-04 | 4 | Smith Edward F III | CNAT | Stock Option (Right to Buy) | D | 5,17 | 40 000 | 40 000 | |||||
| 2018-02-05 | 2017-11-14 | 4 | Smith Edward F III | CNAT | Common Stock | D | 3,4800 | 4 461 | 16 | 4 461 | ||||
| 2018-02-05 | 2018-02-04 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 5,17 | 70 000 | 70 000 | |||||
| 2018-02-05 | 2018-02-04 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 5,17 | 16 000 | 16 000 | |||||
| 2017-09-01 | 2017-08-31 | 4 | Marshall Keith W | CNAT | Stock Option (Right to Buy) | D | 5,74 | 525 000 | 525 000 | |||||
| 2017-06-26 | 2017-06-22 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 4,96 | 20 000 | 20 000 | |||||
| 2017-06-26 | 2017-06-22 | 4 | KISNER DANIEL L | CNAT | Stock Option (Right to Buy) | D | 4,96 | 20 000 | 20 000 | |||||
| 2017-06-26 | 2017-06-22 | 4 | Klassen Preston | CNAT | Stock Option (Right to Buy) | D | 4,96 | 20 000 | 20 000 | |||||
| 2017-06-26 | 2017-06-22 | 4 | Scopa James Paul | CNAT | Stock Option (Right to Buy) | D | 4,96 | 20 000 | 20 000 | |||||
| 2017-06-26 | 2017-06-22 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 4,96 | 45 000 | 45 000 | |||||
| 2017-04-07 | 3 | VANDERTIE MICHELLE L See footnote. | CNAT | Common Stock | I | 9 956 | ||||||||
| 2017-04-07 | 3 | VANDERTIE MICHELLE L See footnote. | CNAT | Common Stock | I | 9 956 | ||||||||
| 2017-02-07 | 2017-02-06 | 4 | LARUE WILLIAM R | CNAT | Stock Option (Right to Buy) | D | 5,09 | 30 000 | 30 000 | |||||
| 2017-02-02 | 3 | RIPLEY DANIEL L. See footnote. | CNAT | Common Stock | I | 55 402 | ||||||||
| 2017-02-02 | 3 | RIPLEY DANIEL L. See footnote. | CNAT | Common Stock | I | 55 402 | ||||||||
| 2017-02-02 | 2017-01-26 | 4 | RIPLEY DANIEL L. | CNAT | Stock Option (Right to Buy) | D | 4,21 | 73 000 | 73 000 | |||||
| 2017-02-01 | 2017-01-26 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 4,21 | 172 500 | 172 500 | |||||
| 2017-02-01 | 2017-01-26 | 4 | Cashion Charles | CNAT | Stock Option (Right to Buy) | D | 4,21 | 57 500 | 57 500 | |||||
| 2017-02-01 | 2017-01-26 | 4 | Hagerty David T | CNAT | Stock Option (Right to Buy) | D | 4,21 | 100 625 | 100 625 | |||||
| 2017-02-01 | 2017-01-26 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 4,21 | 100 625 | 100 625 | |||||
| 2017-02-01 | 2017-01-26 | 4 | Smith Edward F III | CNAT | Stock Option (Right to Buy) | D | 4,21 | 57 500 | 57 500 | |||||
| 2017-01-11 | 2017-01-09 | 4 | Cashion Charles | CNAT | Stock Option (Right to Buy) | D | 0,99 | -42 424 | 0 | |||||
| 2017-01-11 | 2017-01-09 | 4 | Cashion Charles | CNAT | Common Stock | D | 0,9900 | 42 424 | 42 | 42 424 | ||||
| 2016-12-30 | 2014-02-19 | 4/A | KISNER DANIEL L | CNAT | Common Stock | I | 3 145 | 3 145 | ||||||
| 2016-12-30 | 2016-12-28 | 4 | KISNER DANIEL L | CNAT | Common Stock | I | 2 310 | 5 455 | ||||||
| 2016-12-22 | 2016-12-20 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 0,99 | -5 051 | 207 070 | |||||
| 2016-12-22 | 2016-12-20 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 1,24 | -36 363 | 0 | |||||
| 2016-12-22 | 2016-12-20 | 4 | Mento Steven J | CNAT | Common Stock | D | 0,9900 | 5 051 | 5 | 41 414 | ||||
| 2016-12-22 | 2016-12-20 | 4 | Mento Steven J | CNAT | Common Stock | D | 1,2400 | 36 363 | 45 | 36 363 | ||||
| 2016-10-31 | 2016-10-27 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 0,25 | -18 181 | 0 | |||||
| 2016-10-31 | 2016-10-27 | 4 | Van Wart Harold | CNAT | Common Stock | D | 0,2500 | 18 181 | 5 | 18 181 | ||||
| 2016-06-27 | 2016-06-23 | 4 | Malik Shahzad | CNAT | Stock Option (Right to Buy) | D | 2,13 | 20 000 | 20 000 | |||||
| 2016-06-24 | 2016-06-23 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 2,13 | 45 000 | 45 000 | |||||
| 2016-06-24 | 2016-06-23 | 4 | KISNER DANIEL L | CNAT | Stock Option (Right to Buy) | D | 2,13 | 20 000 | 20 000 | |||||
| 2016-06-24 | 2016-06-23 | 4 | Scopa James Paul | CNAT | Stock Option (Right to Buy) | D | 2,13 | 20 000 | 20 000 | |||||
| 2016-06-24 | 2016-06-23 | 4 | Klassen Preston | CNAT | Stock Option (Right to Buy) | D | 2,13 | 20 000 | 20 000 | |||||
| 2016-06-24 | 2016-06-23 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 2,13 | 20 000 | 20 000 | |||||
| 2016-04-04 | 2016-04-01 | 4 | Smith Edward F III | CNAT | Stock Option (Right to Buy) | D | 2,53 | 100 000 | 100 000 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 1,85 | 37 500 | 37 500 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 1,85 | 187 500 | 187 500 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Cashion Charles | CNAT | Stock Option (Right to Buy) | D | 1,85 | 12 500 | 12 500 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Cashion Charles | CNAT | Stock Option (Right to Buy) | D | 1,85 | 50 000 | 50 000 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Hagerty David T | CNAT | Stock Option (Right to Buy) | D | 1,85 | 21 875 | 21 875 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Hagerty David T | CNAT | Stock Option (Right to Buy) | D | 1,85 | 109 375 | 109 375 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 1,85 | 21 875 | 21 875 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 1,85 | 109 375 | 109 375 | |||||
| 2015-06-15 | 2015-06-11 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 5,52 | 35 000 | 35 000 | |||||
| 2015-06-15 | 2015-06-11 | 4 | KISNER DANIEL L | CNAT | Stock Option (Right to Buy) | D | 5,52 | 15 000 | 15 000 | |||||
| 2015-06-15 | 2015-06-11 | 4 | LACASSE LOUIS P | CNAT | Stock Option (Right to Buy) | D | 5,52 | 15 000 | 15 000 | |||||
| 2015-06-15 | 2015-06-11 | 4 | Malik Shahzad | CNAT | Stock Option (Right to Buy) | D | 5,52 | 15 000 | 15 000 | |||||
| 2015-06-15 | 2015-06-11 | 4 | Scopa James Paul | CNAT | Stock Option (Right to Buy) | D | 5,52 | 15 000 | 15 000 | |||||
| 2015-06-15 | 2015-06-11 | 4 | Klassen Preston | CNAT | Stock Option (Right to Buy) | D | 5,52 | 15 000 | 15 000 | |||||
| 2015-06-15 | 2015-06-11 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 5,52 | 15 000 | 15 000 | |||||
| 2015-04-10 | 2015-04-08 | 4 | KISNER DANIEL L | CNAT | Common Stock | D | 5,7500 | 4 000 | 23 | 7 145 | ||||
| 2015-02-25 | 2015-02-23 | 4 | Cashion Charles | CNAT | Stock Option (Right to Buy) | D | 6,40 | 50 000 | 50 000 | |||||
| 2015-02-25 | 2015-02-23 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 6,40 | 50 000 | 50 000 | |||||
| 2015-02-25 | 2015-02-23 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 6,40 | 150 000 | 150 000 | |||||
| 2015-02-25 | 2015-02-23 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 6,40 | 100 000 | 100 000 | |||||
| 2015-02-06 | 2014-04-02 | 5 | Cashion Charles See footnote. | CNAT | Common Stock | I | -5 000 | 144 738 | ||||||
| 2014-10-03 | 2014-10-01 | 4 | Hagerty David T | CNAT | Stock Option (Right to Buy) | D | 5,92 | 175 000 | 175 000 | |||||
| 2014-06-23 | 2014-06-19 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 7,97 | 35 000 | 35 000 | |||||
| 2014-06-23 | 2014-06-19 | 4 | LACASSE LOUIS P | CNAT | Stock Option (Right to Buy) | D | 7,97 | 15 000 | 15 000 | |||||
| 2014-06-23 | 2014-06-19 | 4 | Malik Shahzad | CNAT | Stock Option (Right to Buy) | D | 7,97 | 15 000 | 15 000 | |||||
| 2014-06-23 | 2014-06-19 | 4 | Scopa James Paul | CNAT | Stock Option (Right to Buy) | D | 7,97 | 15 000 | 15 000 | |||||
| 2014-06-23 | 2014-06-19 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 7,97 | 15 000 | 15 000 | |||||
| 2014-02-25 | 2014-02-19 | 4 | KISNER DANIEL L | CNAT | Common Stock | D | 3 145 | 3 145 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | Aberdare GP III, L.L.C. By Aberdare GP III, L.L.C. | CNAT | Common Stock | I | -36 634 | 0 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | Aberdare GP III, L.L.C. By Aberdare GP III, L.L.C. | CNAT | Common Stock | I | 36 634 | 36 634 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Common Stock | I | -30 216 | 22 203 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | -1 283 589 | 943 355 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | KLINGENSTEIN PAUL H By Klingenstein-Bole 2003 Irrevocable Children's Trust | CNAT | Common Stock | I | 8 731 | 8 731 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | KLINGENSTEIN PAUL H | CNAT | Common Stock | D | 20 322 | 20 322 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | KLINGENSTEIN PAUL H By Aberdare GP III, L.L.C. | CNAT | Common Stock | I | -36 634 | 0 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | KLINGENSTEIN PAUL H By Aberdare GP III, L.L.C. | CNAT | Common Stock | I | 36 634 | 36 634 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Common Stock | I | -30 216 | 22 203 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | -1 283 589 | 943 355 | ||||||
| 2014-02-11 | 2014-02-07 | 4 | KISNER DANIEL L | CNAT | Stock Option (Right to Buy) | D | 9,45 | 30 000 | 30 000 | |||||
| 2014-02-11 | 2014-02-07 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 9,45 | 400 000 | 400 000 | |||||
| 2014-02-11 | 2014-02-07 | 4 | Cashion Charles | CNAT | Stock Option (Right to Buy) | D | 9,45 | 50 000 | 50 000 | |||||
| 2014-02-11 | 2014-02-07 | 4 | Klassen Preston | CNAT | Stock Option (Right to Buy) | D | 9,45 | 30 000 | 30 000 | |||||
| 2014-02-11 | 2014-02-07 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 9,45 | 50 000 | 50 000 | |||||
| 2014-02-11 | 2014-02-07 | 4 | BURGESS GARY C. | CNAT | Stock Option (Right to Buy) | D | 9,45 | 50 000 | 50 000 | |||||
| 2014-01-10 | 2014-01-08 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 0,99 | -12 121 | 0 | |||||
| 2014-01-10 | 2014-01-08 | 4 | HALE DAVID F | CNAT | Common Stock | D | 0,9900 | 12 121 | 12 | 24 242 | ||||
| 2013-09-27 | 2013-09-26 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 2,31 | -12 121 | 0 | |||||
| 2013-09-27 | 2013-09-26 | 4 | HALE DAVID F | CNAT | Common Stock | D | 2,3100 | 12 121 | 28 | 12 121 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Scopa James Paul | CNAT | Stock Option (Right to Buy) | D | 11,00 | 30 000 | 30 000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Scopa James Paul | CNAT | Warrant to Purchase Common Stock (Right to Buy) | I | 7,43 | 32 220 | 32 220 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Scopa James Paul | CNAT | Warrant to Purchase Series B Preferred Stock (Right to Buy) | I | 0,90 | -265 837 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Scopa James Paul | CNAT | Series B Convertible Preferred Stock | I | -8 333 334 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Scopa James Paul | CNAT | Common Stock | I | 11,0000 | 165 265 | 1 818 | 1 192 080 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Scopa James Paul | CNAT | Common Stock | I | 11,0000 | 16 716 | 184 | 1 026 815 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Scopa James Paul | CNAT | Common Stock | I | 1 010 099 | 1 010 099 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP See footnotes | CNAT | Warrants to Purchase Shares of Series A Preferred Stock | I | -577 599 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP See footnotes | CNAT | Series B Preferred Stock | I | -5 576 786 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP See footnotes | CNAT | Series A Preferred Stock | I | -10 000 000 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP See footnotes | CNAT | Common Stock | I | 11,0000 | 190 054 | 2 091 | 2 166 836 | ||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP | CNAT | Common Stock | I | 11,0000 | 19 223 | 211 | 1 976 782 | ||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP | CNAT | Common Stock | I | 11,0000 | -535 | -6 | 1 957 559 | ||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP | CNAT | Common Stock | I | 0,0825 | 70 003 | 6 | 1 958 094 | ||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP See footnotes | CNAT | Common Stock | I | 1 888 091 | 1 888 091 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 11,00 | 50 000 | 50 000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | HALE DAVID F | CNAT | Series A Preferred Stock | I | -162 356 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | HALE DAVID F | CNAT | Common Stock | I | 11,0000 | 2 588 | 28 | 143 739 | ||||
| 2013-08-01 | 2013-07-30 | 4 | HALE DAVID F | CNAT | Common Stock | I | 11,0000 | 261 | 3 | 141 151 | ||||
| 2013-08-01 | 2013-07-30 | 4 | HALE DAVID F | CNAT | Common Stock | I | 19 679 | 140 890 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | LACASSE LOUIS P | CNAT | Stock Option (Right to Buy) | D | 11,00 | 30 000 | 30 000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | LACASSE LOUIS P | CNAT | Series B Preferred Stock | I | -5 555 556 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | LACASSE LOUIS P | CNAT | Common Stock | I | 11,0000 | 123 950 | 1 363 | 809 887 | ||||
| 2013-08-01 | 2013-07-30 | 4 | LACASSE LOUIS P | CNAT | Common Stock | I | 11,0000 | 12 537 | 138 | 685 937 | ||||
| 2013-08-01 | 2013-07-30 | 4 | LACASSE LOUIS P | CNAT | Common Stock | I | 673 400 | 673 400 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad | CNAT | Stock Option (Right to Buy) | D | 11,00 | 30 000 | 30 000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad See footnotes | CNAT | Warrants to Purchase Shares of Series A Preferred Stock | I | -577 599 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad See footnotes | CNAT | Series B Preferred Stock | I | -5 576 786 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad See footnotes | CNAT | Series A Preferred Stock | I | -10 000 000 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad | CNAT | Common Stock | I | 11,0000 | 190 054 | 2 091 | 2 166 836 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad | CNAT | Common Stock | I | 11,0000 | 19 223 | 211 | 1 976 782 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad | CNAT | Common Stock | I | 11,0000 | -535 | -6 | 1 957 559 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad | CNAT | Common Stock | I | 0,0825 | 70 003 | 6 | 1 958 094 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad See footnotes | CNAT | Common Stock | I | 1 888 091 | 1 888 091 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Mento Steven J | CNAT | Series A Preferred Stock | I | -786 417 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Mento Steven J | CNAT | Common Stock | I | 11,0000 | 13 800 | 152 | 385 669 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Mento Steven J | CNAT | Common Stock | I | 11,0000 | 1 395 | 15 | 371 869 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Mento Steven J | CNAT | Common Stock | I | 95 323 | 370 474 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Cashion Charles | CNAT | Series A Preferred Stock | I | -355 352 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Cashion Charles | CNAT | Common Stock | I | 43 072 | 149 738 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier | CNAT | Stock Option (Right to Buy) | D | 11,00 | 30 000 | 30 000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Warrants to Purchase Shares of Series A Preferred Stock | I | -385 070 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Series B Preferred Stock | I | -3 717 861 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Series A Preferred Stock | I | -6 666 668 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Common Stock | I | 11,0000 | 165 525 | 1 821 | 1 487 320 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Common Stock | I | 11,0000 | 16 742 | 184 | 1 321 795 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Common Stock | I | 11,0000 | -352 | -4 | 1 305 053 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Common Stock | I | 46 675 | 1 305 405 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Common Stock | I | 1 258 730 | 1 258 730 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | EVNIN LUKE | CNAT | Warrant to Purchase Common Stock (Right to Buy) | I | 7,43 | 32 220 | 32 220 | |||||
| 2013-08-01 | 2013-07-30 | 4 | EVNIN LUKE | CNAT | Warrant to Purchase Series B Preferred Stock (Right to Buy) | I | 0,90 | -265 837 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | EVNIN LUKE | CNAT | Series B Convertible Preferred Stock | I | -8 333 334 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | EVNIN LUKE | CNAT | Common Stock | I | 11,0000 | 165 265 | 1 818 | 1 192 080 | ||||
| 2013-08-01 | 2013-07-30 | 4 | EVNIN LUKE | CNAT | Common Stock | I | 11,0000 | 16 716 | 184 | 1 026 815 | ||||
| 2013-08-01 | 2013-07-30 | 4 | EVNIN LUKE | CNAT | Common Stock | I | 1 010 099 | 1 010 099 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | MPM BioVentures IV QP LP | CNAT | Warrant to Purchase Common Stock (Right to Buy) | I | 7,43 | 32 220 | 32 220 | |||||
| 2013-08-01 | 2013-07-30 | 4 | MPM BioVentures IV QP LP | CNAT | Warrant to Purchase Series B Preferred Stock (Right to Buy) | I | 0,90 | -265 837 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | MPM BioVentures IV QP LP | CNAT | Series B Convertible Preferred Stock | I | -8 333 334 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | MPM BioVentures IV QP LP | CNAT | Common Stock | I | 11,0000 | 165 265 | 1 818 | 1 192 080 | ||||
| 2013-08-01 | 2013-07-30 | 4 | MPM BioVentures IV QP LP | CNAT | Common Stock | I | 11,0000 | 16 716 | 184 | 1 026 815 | ||||
| 2013-08-01 | 2013-07-30 | 4 | MPM BioVentures IV QP LP | CNAT | Common Stock | I | 1 010 099 | 1 010 099 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Spada Alfred P. | CNAT | Series A Preferred Stock | I | -363 927 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Spada Alfred P. | CNAT | Common Stock | I | 44 112 | 235 021 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 11,00 | 30 000 | 30 000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Warrants to Purchase Shares of Series A Preferred Stock | D | -385 070 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Series B Preferred Stock | D | -3 717 861 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Series A Preferred Stock | D | -6 666 668 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Common Stock | D | 11,0000 | 165 525 | 1 821 | 1 487 320 | ||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Common Stock | D | 11,0000 | 16 742 | 184 | 1 321 795 | ||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Common Stock | D | 11,0000 | -352 | -4 | 1 305 053 | ||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Common Stock | D | 46 675 | 1 305 405 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Common Stock | D | 1 258 730 | 1 258 730 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 7,43 | 120 | 120 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Series B Preferred Stock | I | 0,90 | -997 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | -1 727 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | 1 727 | 1 727 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | -5 701 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | -8 552 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Series B Preferred Stock | I | -137 626 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Series A Preferred Stock | I | -246 775 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 7,43 | 5 131 | 5 131 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,90 | -42 336 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | -73 395 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | 73 395 | 73 395 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | -242 205 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | -363 308 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Series B Preferred Stock | I | -5 846 236 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Series A Preferred Stock | I | -10 483 166 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 11,0000 | 2 470 | 27 | 52 419 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 11,0000 | 251 | 3 | 49 949 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 11,0000 | -14 | -0 | 49 698 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 0,0825 | 1 727 | 0 | 49 712 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 46 594 | 47 985 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 11,0000 | 104 952 | 1 154 | 2 226 944 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 11,0000 | 10 614 | 117 | 2 121 992 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 11,0000 | -552 | -6 | 2 111 378 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 0,0825 | 73 395 | 6 | 2 111 930 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 1 979 321 | 2 038 535 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H | CNAT | Stock Option (right to buy) | D | 11,00 | 30 000 | 30 000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 7,43 | 120 | 120 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Series B Preferred Stock | I | 0,90 | -997 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | -1 727 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | 1 727 | 1 727 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | -5 701 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | -8 552 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Series B Preferred Stock | I | -137 626 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Series A Preferred Stock | I | -246 775 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 7,43 | 5 131 | 5 131 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,90 | -42 336 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | -73 395 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | 73 395 | 73 395 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | -242 205 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | -363 308 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Series B Preferred Stock | I | -5 846 236 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Series A Preferred Stock | I | -10 483 166 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 11,0000 | 2 470 | 27 | 52 419 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 11,0000 | 251 | 3 | 49 949 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 11,0000 | -14 | -0 | 49 698 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 0,0825 | 1 727 | 0 | 49 712 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 46 594 | 47 985 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 11,0000 | 104 952 | 1 154 | 2 226 944 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 11,0000 | 10 614 | 117 | 2 121 992 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 11,0000 | -552 | -6 | 2 111 378 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 0,0825 | 73 395 | 6 | 2 111 930 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 1 979 321 | 2 038 535 | ||||||
| 2013-07-24 | 3 | HALE DAVID F | CNAT | Common Stock | I | 121 211 | ||||||||
| 2013-07-24 | 3 | Mento Steven J | CNAT | Common Stock | I | 275 151 | ||||||||
| 2013-07-24 | 3 | Cashion Charles | CNAT | Common Stock | I | 106 666 | ||||||||
| 2013-07-24 | 3 | Spada Alfred P. | CNAT | Common Stock | I | 190 909 | ||||||||
| 2013-07-24 | 3 | BURGESS GARY C. | CNAT | Common Stock | D | 121 212 | ||||||||
| 2013-07-24 | 3 | Aberdare Partners III LP By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 1 391 | ||||||||
| 2013-07-24 | 3 | Aberdare Partners III LP By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 59 214 | ||||||||
| 2013-07-24 | 3 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 1 391 | ||||||||
| 2013-07-24 | 3 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 59 214 |
P
Otwarty rynek lub prywatny zakup niepochodnych lub pochodnych papierów wartościowych
S
Otwarty rynek lub prywatna sprzedaż niepochodnych lub pochodnych papierów wartościowych
A
Grant, nagroda lub inne nabycie papierów wartościowych od spółki (np. opcja)
C
Konwersja instrumentu pochodnego
D
Sprzedaż lub przeniesienie papierów wartościowych z powrotem do spółki
F
Zapłata ceny wykonania lub zobowiązania podatkowego z wykorzystaniem części papierów wartościowych otrzymanych od spółki
G
Darowizna papierów wartościowych przez lub na rzecz insidera
K
Swapy kapitałowe i podobne transakcje zabezpieczające
M
Wykonanie lub konwersja pochodnego papieru wartościowego otrzymanego od spółki (takiego jak opcja)
V
Transakcja dobrowolnie zgłoszona na Formularzu 4
J
Inne (wraz z przypisem opisującym transakcję)
